JP2022540620A5 - - Google Patents
Info
- Publication number
- JP2022540620A5 JP2022540620A5 JP2022501205A JP2022501205A JP2022540620A5 JP 2022540620 A5 JP2022540620 A5 JP 2022540620A5 JP 2022501205 A JP2022501205 A JP 2022501205A JP 2022501205 A JP2022501205 A JP 2022501205A JP 2022540620 A5 JP2022540620 A5 JP 2022540620A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- seq
- binding fragment
- tslp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962873051P | 2019-07-11 | 2019-07-11 | |
| US62/873,051 | 2019-07-11 | ||
| PCT/US2020/041642 WO2021007533A1 (en) | 2019-07-11 | 2020-07-10 | Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022540620A JP2022540620A (ja) | 2022-09-16 |
| JP2022540620A5 true JP2022540620A5 (https=) | 2023-06-19 |
| JP7597784B2 JP7597784B2 (ja) | 2024-12-10 |
Family
ID=74114844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022501205A Active JP7597784B2 (ja) | 2019-07-11 | 2020-07-10 | 胸腺間質性リンパ球新生因子（ｔｓｌｐ）受容体シグナル伝達に干渉する薬剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12435131B2 (https=) |
| EP (1) | EP3996747A4 (https=) |
| JP (1) | JP7597784B2 (https=) |
| KR (1) | KR20220033504A (https=) |
| CN (1) | CN114401741A (https=) |
| AU (1) | AU2020311432A1 (https=) |
| CA (1) | CA3147044A1 (https=) |
| WO (1) | WO2021007533A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250277022A1 (en) * | 2021-02-04 | 2025-09-04 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing thymic stromal lymphopoietin and uses thereof |
| CN117209603B (zh) * | 2021-12-02 | 2024-02-27 | 北京东方百泰生物科技股份有限公司 | 一种抗tslp的单克隆抗体、其抗原结合片段及其应用 |
| US12110324B2 (en) | 2022-07-22 | 2024-10-08 | Flagship Pioneering Innovations Vi, Llc | Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP) |
| EP4678659A1 (en) * | 2023-02-23 | 2026-01-14 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Monoclonal antibody preparation targeting tslp |
| WO2024264002A2 (en) * | 2023-06-22 | 2024-12-26 | Paragon Therapeutics, Inc. | Antibodies that bind tslp and tslpr and methods of use |
| WO2025195445A1 (zh) * | 2024-03-21 | 2025-09-25 | 北京三诺佳邑生物技术有限责任公司 | 特异性结合light和tslp的多特异性抗体以及组合物及其应用 |
| WO2025214333A1 (zh) * | 2024-04-08 | 2025-10-16 | 江苏恒瑞医药股份有限公司 | 抗tslp抗体治疗与tslp相关的炎症疾病的方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ES2156149T3 (es) | 1992-12-04 | 2001-06-16 | Medical Res Council | Proteinas de union multivalente y multiespecificas, su fabricacion y su uso. |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| HUP0301208A2 (hu) | 1999-02-12 | 2003-08-28 | Genetics Institute, Llc | B7-molekulákkal reagáló humanizált immunglobulin és az ezekkel végzett kezelési eljárások |
| EP1793856A2 (en) | 2004-08-20 | 2007-06-13 | Amgen Inc. | Methods and compositions for treating allergic inflammation |
| WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| AU2006232287B2 (en) | 2005-03-31 | 2011-10-06 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| GB0603683D0 (en) * | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
| TW200806317A (en) * | 2006-03-20 | 2008-02-01 | Wyeth Corp | Methods for reducing protein aggregation |
| JP2009541275A (ja) | 2006-06-22 | 2009-11-26 | ノボ・ノルデイスク・エー／エス | 二重特異性抗体の生産 |
| US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| WO2010129304A2 (en) | 2009-04-27 | 2010-11-11 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| RU2016122041A (ru) | 2013-11-06 | 2017-12-11 | ЭББВИ СТЕМСЕНТРКС ЭлЭлСи | Новые анти-клаудин антитела и способы их применения |
| KR20170052526A (ko) | 2014-03-13 | 2017-05-12 | 프로테나 바이오사이언시즈 리미티드 | 다발성 경화증에 대한 병용 치료 |
| KR102553870B1 (ko) | 2014-03-27 | 2023-07-10 | 버드 락 바이오, 인크. | 인간 카나비노이드 1(cb1) 수용체 결합 항체 |
| TW201617368A (zh) | 2014-09-05 | 2016-05-16 | 史坦森特瑞斯公司 | 新穎抗ｍｆｉ２抗體及使用方法 |
| US9535074B2 (en) | 2014-09-08 | 2017-01-03 | Merck Sharp & Dohme Corp. | Immunoassay for soluble PD-L1 |
| JP2018080114A (ja) | 2015-05-29 | 2018-05-24 | 株式会社アールテック・ウエノ | 抗ヒトｖａｐ−１モノクローナル抗体 |
| CN107922500A (zh) * | 2015-06-29 | 2018-04-17 | 洛克菲勒大学 | 具有增强的激动剂活性的抗cd40抗体 |
| HRP20210650T1 (hr) * | 2015-09-09 | 2021-05-28 | Novartis Ag | Protutijela koja vežu timusni stromalni limfopoetin (tslp) i postupci uporabe protutijela |
| CA3020633A1 (en) | 2016-04-13 | 2017-10-19 | Sanofi | Trispecific and/or trivalent binding proteins |
| WO2018031258A1 (en) | 2016-08-12 | 2018-02-15 | Janssen Biotech, Inc. | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions |
| KR102666879B1 (ko) | 2017-04-12 | 2024-05-23 | 암젠 인크 | 항-tslp 항체를 이용한 천식의 치료 |
| WO2019126594A2 (en) | 2017-12-20 | 2019-06-27 | Radimmune Therapeutics, Inc. | Antibodies to centrin-1, methods of making, and uses thereof |
-
2020
- 2020-07-10 CA CA3147044A patent/CA3147044A1/en active Pending
- 2020-07-10 WO PCT/US2020/041642 patent/WO2021007533A1/en not_active Ceased
- 2020-07-10 AU AU2020311432A patent/AU2020311432A1/en active Pending
- 2020-07-10 JP JP2022501205A patent/JP7597784B2/ja active Active
- 2020-07-10 KR KR1020227004436A patent/KR20220033504A/ko active Pending
- 2020-07-10 US US17/625,934 patent/US12435131B2/en active Active
- 2020-07-10 CN CN202080062753.9A patent/CN114401741A/zh active Pending
- 2020-07-10 EP EP20836933.0A patent/EP3996747A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022540620A5 (https=) | ||
| JP6986965B2 (ja) | 抗ｐｄ−１抗体 | |
| CA2987118C (en) | A pdl-1 antibody, pharmaceutical composition thereof and use thereof | |
| AU2014361473B2 (en) | PD-1 antibody, antigen-binding fragment thereof, and medical application thereof | |
| CA2698382C (en) | Antigen binding proteins capable of binding thymic stromal lymphopoietin | |
| CN113527485B (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
| KR101676269B1 (ko) | 인터루킨-13 결합 단백질 | |
| JP2019172677A (ja) | 抗ｐｄ−ｌ１抗体並びにその治療及び診断のための使用 | |
| EP3892634A1 (en) | Anti-cd40 antibody, antigen binding fragment and pharmaceutical use thereof | |
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| CN113603784A (zh) | 抗-ctla-4抗体及其使用方法 | |
| EP3632932A1 (en) | Anti-cd40 antibody, antigen binding fragment thereof and medical use thereof | |
| CN112513088B (zh) | 抗ox40抗体、其抗原结合片段及其医药用途 | |
| JP2022533538A5 (https=) | ||
| JP2021510064A (ja) | 細胞傷害誘導治療剤 | |
| AU2022332499A1 (en) | Fap/cd40 binding molecule and medicinal use thereof | |
| JP2024540148A5 (https=) | ||
| JP7698635B2 (ja) | 抗幹細胞因子抗体及びその使用方法 | |
| WO2021258337A1 (en) | Human monoclonal antibodies against tigit for immune related diseases | |
| CN115215937B (zh) | 抗人masp-2抗体及其制备方法和应用 | |
| TW202515919A (zh) | 抗ｔｒｅｍ２抗體及使用方法 | |
| CN114761042A (zh) | Il-38特异性抗体 | |
| WO2025195358A1 (zh) | Pd-1结合蛋白及医药用途 | |
| TW202521578A (zh) | Ｂｔｎ３ａ結合蛋白及其醫藥用途 | |
| WO2022095698A1 (zh) | 抗人cd38抗体及其制备方法和用途 |